01332 TOUYUN BIOTECH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.31X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | N/A | Net Margin | N/A |
Total Debt/Equity | N/A | Return on Equity | N/A |
Price/Book | N/A | Return on Assets | N/A |
(HKD 0.100) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -88.11 | -268.94 | -198.07 | -72.95 | -168.78 |
---|---|---|---|---|---|
Net Profit Growth (%) | +67.2 | -35.8 | -171.5 | +56.8 | +15.8 |
Earnings Per Share (HKD) | -0.031 | -0.096 | -0.071 | -0.026 | -0.063 |
Earnings Per Share Growth (%) | +67.2 | -35.7 | -170.5 | +58.7 | +22.8 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | -0.030 | 0.000 | 0.094 | 0.168 | 0.176 |
Auditors' Opinion | Qualified | Qualified | Unqualified # | Qualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-23 21:40:20
Latest Result
(HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 152.299 | 198.032 | -23.1 | 323.334 |
Operating Result | -87.333 | -270.54 | -67.7 | -196.368 |
Associates | 0 | 0 | N/A | 0 |
Profit Before Taxation | -88.366 | -272.585 | -67.6 | -199.183 |
Taxation | -0.326 | -0.016 | +1,937.5 | 3.473 |
Profit /( Loss) After Taxation | -88.04 | -272.569 | -67.7 | -202.656 |
Minority Interests | 0.067 | -3.63 | -101.8 | -4.591 |
Net Profit | -88.107 | -268.939 | -67.2 | -198.065 |
Earnings Per Share () | -0.0314 | -0.0958 | -67.2 | -0.0706 |
Announcement Date | 2025-03-26 | 2024-03-28 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-23 21:40:25